1.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: 050808, CDR0000660044, P30CA072720, CINJ-050808, NCT01018836
|
2.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2011-02597, 090906, U01CA132194, CINJ-090906, 8850, NCT01303341
|